FindTrial
Sign In

SPINAL ANESTHESIA IN THE CAESAREAN CUT LEVOBUPIVACAINE VERSUS ROPIVACAINE VERSUS HYPERBARIC BUPIVACAINE - ND

SPINAL ANESTHESIA IN THE CAESAREAN CUT LEVOBUPIVACAINE VERSUS ROPIVACAINE VERSUS HYPERBARIC BUPIVACAINE - ND

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-001506-81-IT
Enrollment
Unknown
Registered
2006-11-09
Start date
2006-05-03
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subaracnoidea anesthesia in the Caesarean Cut MedDRA version: 8.1 Level: LLT Classification code 10006924 Term: Caesarean section

Interventions

Trade Name: NAROPINA 7,5MG/ML*5F POLYAMP10 Pharmaceutical Form: Solution for injection INN or Proposed INN: Ropivacaine Concentration unit: mg milligram(s) Concentration type: equal Concentration numb

Sponsors

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: female, ASA 1-2, age comprised between 18 and 40 years, Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: refusal of the patient,

Design outcomes

Primary

MeasureTime frame
Main Objective: To characterize the local anaesthetic more suitable to being used for subaracoidea way in the TC.;Secondary Objective: to estimate onset and intensity of the block anaesthetic satisfactory the surgical requirements;;Primary end point(s): block satisfactory anaesthetic—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026